Tonghua Baishan Pharmaceutical Stock Co., Ltd.

This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin.

This product has good antibacterial effect on superficial fungi such as Trichophyton, Microsporum, Epidermophyton, etc. It has no antibacterial effect on Candida, Cryptococcus, Histoplasma, Sporothrix, Blastomyces, Coccidioides, etc. This drug inhibits the growth of fungi by interfering with the synthesis of fungal nucleic acids.

This product is a gastrin receptor antagonist, which can significantly inhibit the secretion of gastric acid and pepsin caused by gastrin, but has no obvious effect on the gastric acid secretion caused by histamine and vagus nerve stimulation. It can increase the content of hexosamine in the gastric mucosa, promote glycoprotein synthesis, protect the gastric mucosa and promote healing, improve the symptoms of peptic ulcer and promote ulcer healing. The use of this product to treat peptic ulcer and gastritis does not cause rebound of gastric acid secretion, and gastric acid secretion can remain at a normal level for up to half a year after the treatment is terminated. In addition, this product has a choleretic effect, which prevents stone formation and promotes bile duct health by stimulating bile acid-independent bile secretion, changing the stone-forming factors in bile, and antagonizing CCK.